Adding Interventional DED Treatment to Your Practice - Report - MDSpire

Adding Interventional DED Treatment to Your Practice

  • By

  • Neel R. Desai, MD

  • January 1, 2026

  • 14 min

Share

Clinical Report: Adding Interventional DED Treatment to Your Practice

Overview

This report discusses the shift towards interventional treatments for dry eye disease (DED), highlighting the benefits of team-based care and specific treatment modalities. The adoption of these strategies can enhance patient outcomes and streamline practice operations.

Background

Dry eye disease is a prevalent condition that significantly impacts patient quality of life and poses challenges for healthcare providers. Traditional management strategies have relied heavily on topical therapies, which often lead to poor compliance and increased burdens on both patients and practices. An interventional approach offers a promising alternative, allowing for more effective and efficient treatment options.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Interventional treatments for DED can reduce the compliance burden associated with topical therapies.
  • Lacrimal occlusion with hyaluronic acid gel is effective as a first-line therapy for all types of DED.
  • Team-based care pathways can enhance treatment delivery and patient education.
  • Immediate symptomatic improvement can be achieved with certain interventional therapies, improving patient satisfaction.
  • Structured diagnostic and follow-up pathways are essential for integrating interventional treatments into practice.

Clinical Implications

Clinicians should consider adopting an interventional approach to DED management to improve patient outcomes and reduce the administrative burden associated with traditional therapies. Implementing team-based care can enhance efficiency and allow physicians to focus on more complex cases.

Conclusion

The transition to interventional treatments for dry eye disease represents a significant advancement in ophthalmic care, promising improved patient experiences and operational efficiencies in clinical practice.

References

  1. Optometric Management, 2021 -- Tools To Start a DED Clinic
  2. Glaucoma Physician, 2026 -- Video: Building an Interventional Glaucoma Practice
  3. Ophthalmology Management, 2022 -- OVERCOME CHALLENGES WITH NEW TECHNOLOGY
  4. Optometric Management, 2020 -- Educate on DED therapeutics
  5. TFOS DEWS III: Management and Therapy - ScienceDirect
  6. Technological Interventions for Dry Eye Disease: A Systematic Review - Springer Nature
  7. TFOS DEWS III: Management and Therapy - ScienceDirect
  8. Technological Interventions for Dry Eye Disease: A Systematic Review and Random-Effects Network Meta-analysis of 3-Month Outcomes | Ophthalmology and Therapy | Springer Nature Link

Original Source(s)

Related Content